Rituximab-based therapy and long-term control of autoimmune autonomic ganglionopathy

Arjun Gupta, Samar Harris, Steven Vernino, Harris V. Naina

Research output: Contribution to journalArticlepeer-review

14 Scopus citations


We present a patient with autoimmune autonomic ganglionopathy (AAG) who had persistently positive ganglionic nicotinic acetylcholine receptor antibody levels despite immunosuppressive therapy. Rituximab-based therapy for an incidental lymphoma was associated with prolonged symptomatic and serological control of AAG.

Original languageEnglish (US)
Pages (from-to)255-258
Number of pages4
JournalClinical Autonomic Research
Issue number4
StatePublished - Aug 7 2015


  • Autoimmune autonomic ganglionopathy
  • Management
  • Rituximab

ASJC Scopus subject areas

  • Clinical Neurology
  • Endocrine and Autonomic Systems


Dive into the research topics of 'Rituximab-based therapy and long-term control of autoimmune autonomic ganglionopathy'. Together they form a unique fingerprint.

Cite this